entertainment -WSS

entertainment

author：focus 2025-10-01 10:58:28 - browse：86842

A caretaker speaks with an elderly Alzheimer's patient at a nursing home. — ALAIN JOCARD/AFP via Getty Images

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant. They found that nearly all of the homozygotes showed biological signs of Alzheimer’s in the brain, and they typically developed dementia and other symptoms, and died sooner, than people with Alzheimer’s who lack APOE4.

The research team also found that APOE4 homozygotes showed a predictable pattern of biomarker changes linked to Alzheimer’s, including a buildup of beta-amyloid and tau, a protein linked to neuron damage and death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： ALS treatment from Biogen, Ionis fails in study

WSS

Robert F. Kennedy is pitching centrism on health, even on abortion

Key House Republican on health care plans exit from Congress

The United States must get value

Cherokee Nation medical school graduates its first class

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

The Readout: Gilead, Bernie Sanders, and other pharma news

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

For Medicare Advantage, Democrats want stronger protections around AI

Sports medicine is finally prioritizing gender equality

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

In age of alternative facts, a scholarly course on calling out crap

The United States must get value

Medicare details structure of new drug price negotiation program

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

The high cost of giving birth even with insurance

Medicare threatens to cut off funding for HCA's Mission hospital

focus

Industry veterans launch new biotech VC with $310M

What we’ve learned from the Aduhelm mess

What a koala virus tells us about the human genome

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Galapagos to make CAR

Fertility clinic egg and embryo storage is a disaster

knowledge

focus

knowledge

Wikipedia